Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-01-21

Clinical Trial Update: Guanfacine for the Treatment of Post Traumatic Stress Disorder (PTSD) [Phase 1]

View source ↗

Summary

This document reports the completion of a Phase 1 clinical trial evaluating guanfacine as a treatment for post-traumatic stress disorder conducted by the US Dep…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Guanfacine (guanfacine)

Snippet

Sponsor: US Department of Veterans Affairs | Conditions: Post-Traumatic Stress Disorder | Phase 1 | Status: COMPLETED